Patents by Inventor Ahmad Ghavami

Ahmad Ghavami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8389565
    Abstract: Methods for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycosidase inhibitors. In some embodiments the compounds of the invention may have the general formula (I) or (II): The synthetic schemes may comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: March 5, 2013
    Assignee: Simon Fraser University
    Inventors: Brian Mario Pinto, Blair D. Johnston, Ahmad Ghavami, Monica Gabriela Szczepina, Hui Liu, Kashinath Sadalapure, Henrik H. Jensen, Nag Sharwan Kumar, Ravindranath Nasi
  • Publication number: 20120329770
    Abstract: The present invention relates to cephalosporin derivatives having ?-lactamase inhibitory activity. The compounds are useful in preventing or treating bacterial resistance to an antibiotic, e.g. a ?-lactam antibiotic. Disclosed herein are compounds that are inhibitors of class B metallo-?-lactamases, as well as class A, C, and D serine ?-lactamases. In some preferred embodiments, the compounds are 3?-thiobenzoate derivatives of a cephalosporin. Pharmaceutical compositions, methods, uses, kits and commercial packages comprising the compounds are also disclosed.
    Type: Application
    Filed: February 25, 2011
    Publication date: December 27, 2012
    Inventors: Gary Igor Dmitrienko, Ahmad Ghavami, Valerie Joy Goodfellow, Jarrod W. Johnson, Anthony Paul Krismanich, Laura Marrone, Thammaiah Viswanatha, Sundaramma Viswanatha
  • Patent number: 7572753
    Abstract: The use of certain tetrazole compounds as fungicides is disclosed wherein said compounds are of the structural formula: wherein: R is selected from the group consisting of phenyl groups of the structural formula: and thienyl groups of the structural formula: and X and Y are each selected from the group consisting of hydrogen, haloalkyl, halogen, and nitro. Novel compounds wherein X is selected from the group consisting of haloalkyl, halogen, and nitro and Y is selected from the group consisting of hydrogen, haloalkyl, halogen, and nitro are also disclosed.
    Type: Grant
    Filed: September 15, 2005
    Date of Patent: August 11, 2009
    Assignee: Chemtura Corporation
    Inventors: Mark A. Dekeyser, Ahmad Ghavami, Robert G. Davis, Sheldon B. Park, Steven J. Hobbs, Clifford Pratt, Gaik-Lean Chee, Daniel Walther
  • Publication number: 20070060631
    Abstract: The use of certain tetrazole compounds as fungicides is disclosed wherein said compounds are of the structural formula: wherein: R is selected from the group consisting of phenyl groups of the structural formula: and thienyl groups of the structural formula: and X and Y are each selected from the group consisting of hydrogen, haloalkyl, halogen, and nitro. Novel compounds wherein X is selected from the group consisting of haloalkyl, halogen, and nitro and Y is selected from the group consisting of hydrogen, haloalkyl, halogen, and nitro are also disclosed.
    Type: Application
    Filed: September 15, 2005
    Publication date: March 15, 2007
    Inventors: Mark Dekeyser, Ahmad Ghavami, Robert Davis, Sheldon Park, Steven Hobbs, Clifford Pratt, Gaik-Lean Chee, Daniel Walther
  • Publication number: 20060247222
    Abstract: Methods for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycosidase inhibitors are described. In some embodiments the compounds of the invention may have the general formula (I) or (II): The synthetic schemes may comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions.
    Type: Application
    Filed: March 2, 2006
    Publication date: November 2, 2006
    Applicant: Simon Fraser University
    Inventors: Brian Pinto, Blair Johnston, Ahmad Ghavami, Monica Szczepina, Hui Liu, Kashinath Sadalapure, Henrik Jensen, Nag Kumar, Ravindranath Nasi
  • Publication number: 20050065139
    Abstract: A method for synthesizing Salacinol, its stereoisomers, and analogues, homologues and other derivatives thereof potentially useful as glycolsidase inhibitors. The compounds of the invention may have the general formula (I) or (II): The synthetic schemes comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions.
    Type: Application
    Filed: June 25, 2004
    Publication date: March 24, 2005
    Inventors: Brian Pinto, Blair Johnston, Monica Szczepina, Hui Liu, Kashinath Sadalapure, Ahmad Ghavami
  • Publication number: 20030191104
    Abstract: A method for synthesizing Salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof having the general formula (I): 1
    Type: Application
    Filed: August 22, 2002
    Publication date: October 9, 2003
    Inventors: Brian M. Pinto, Blair D. Johnston, Ahmad Ghavami
  • Patent number: 6455573
    Abstract: A method for synthesizing Salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof having the general formula (I): The compounds are potentially useful as glycosidase inhibitors. The synthetic schemes comprise reacting a cyclic sulfate with a 5-membered ring sugar containing a heteroatom (X). The heteroatom preferably comprises sulfur, selenium, or nitrogen. The cyclic sulfate and ring sugar reagents may be readily prepared from carbohydrate precursors, such as D-glucose, L-glucose, D-xylose and L-xylose. The target compounds are prepared by opening of the cyclic sulfates by nucleophilic attack of the heteroatoms on the 5-membered ring sugars. The resulting heterocyclic compounds have a stable, inner salt structure comprising a heteroatom cation and a sulfate anion. The synthetic schemes yield various stereoisomers of the target compounds in moderate to good yields with limited side-reactions.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: September 24, 2002
    Assignee: Simon Fraser University
    Inventors: B. Mario Pinto, Blair D. Johnston, Ahmad Ghavami